Plasma insulin levels and incidence of hypertension in African Americans and whites

Archives of Internal Medicine

Volumn 159, Issue 5, 1999, Pages 498-503

  He, Jiang ^a   Klag, Michael J ^b   Caballero, Benjamin ^b   Appel, Lawrence J ^b   Charleston, Jeanne ^b   Whelton, Paul K ^a  

^a TULANE UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR;

EID: 0033535359     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.5.498     Document Type: Article

References (43)

1. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum-insulin inessential hypertension and in peripheral vascular disease. Lancet. 1966; 1:1336-1337.
2. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
3. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
4. Istfan NW, Plaisted CS, Bistrian BR, Blackburn GL. Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension. 1992;19:385-392.
5. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989; 2:419-423.
6. Dengel D, Pratley RE, Hagberg JM, Goldberg AP. Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension. 1994;23:320-324.
7. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
8. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese men. J Clin Endocrinol Metab. 1986;62:1302-1304.
9. Solt VB, Brown NR, Kennedy B, Koltermen OG, Ziegler MG. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens. 1990;3:823-838.
10. Stolk RP, Hoes AW, Pols HA, et al. Insulin, hypertension and antihypertensive drugs in elderly patients: the Rotterdam Study. J Hypertens. 1996;14:237-242.
11. Lind L, Lithell H, Pollare T. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens Suppl. 1993;11(suppl 4):S11-S16.
12. Manolio TA, Savage PJ, Burke GL, et al. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA study. Atherosclerosis. 1990; 10:430-436.
13. Fourner AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med. 1986;80:861-864.
14. Eriksson KF, Lindgarde F. Contribution of estimated insulin resistance and glucose intolerance to essential hypertension. J Intern Med. 1991;735:75-83.
15. Donahue RP, Orchard TJ, Becker DJ, Kuller LH, Drash AL. Sex differences in coronary heart disease risk profile: a possible role for insulin - The Beaver County Study. Am J Epidemiol. 1987;125:650-657.
16. Muller DC, Elahi D, Pratley RE, Tobin J. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab. 1993;76:544-548.
17. Collins VR, Dowse GK, Finch CF, Zimmet PZ. An inconsistent relationship between insulin and blood pressure in three Pacific Island populations. J Clin Epidemiol. 1990;43:1369-1378.
18. Asch S, Wingard DH, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol. 1991;1:23-44.
19. Weisser B, Grune S, Spuhler T, Kistler T, Vetter W. Plasma insulin is correlated with blood pressure only in subjects with a family history of hypertension or diabetes mellitus: results from 11,001 participants in the Heureka Study. J Hypertens Suppl. 1993;11(suppl 5):S308-S309.
20. Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens. 1991;9: 217-223.
21. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension. 1992;20:797-801.
22. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol. 1992;136:12-22.
23. Tsuruta M, Hashimoto R, Adachi H, Imaizumi T, Nomura G. Hyperinsulinaemia as a predictor of hypertension: an 11-year follow-up study in Japan. J Hypertens. 1996;14:483-488.
24. Saad M, Lilioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
25. Chaiken RL, Banerji MA, Huey H, Lebovitz HE. Do blacks with NIDDM have an insulin-resistance syndrome? Diabetes. 1993;42:444-449.
26. Falkner B, Hulman S, Tannenbaum J, Kushner H. Insulin resistance and blood pressure in young black men. Hypertension. 1990;16:706-711.
27. Falkner B, Hulman S, Kushner H. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension. 1993;22:18-25.
28. Donahue RP, Rosemary A, DeCarlo D, et al. Insulin sensitivity and blood pressure in a biethnic sample: the Miami Community Health Study. J Clin Epidemiol. 1996;49:859-864.
29. Satterfield S, Cuttler JA, Langford HG, et al. Trials of hypertension prevention, phase 1 design. Ann Epidemiol. 1991;1:455-471.
30. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention Phase 1. JAMA. 1992;267:1213-1220.
31. Wright BM, Dore LF. A random-zero sphygmomanometer. Lancet. 1970;1:337-338.
32. Keys A, Fidanza F, Karvonen MJ, et al. Indices of relative weight and obesity. J Chronic Dis. 1972;25:329-343.
33. Soeldner JS, Slone D. Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes. 1966;14:771-779.
34. SAS Institute Inc. SAS/STAT User's Guide: Release 6.03. Cary, NC: SAS Institute Inc; 1991.
35. Jiang X, Srinivasan SR, Bao W, Berenson SG. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents: The Bogalusa Heart Study. Am J Hypertens. 1993;6:564-569.
36. Salomaa W, Strandberg TE, Vanhannen H, Naukkarinen V, Sarna S, Miettinen TA. Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ. 1991;302:493-496.
37. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol. 1990;131:1017-1027.
38. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effects of insulin on renal electrolyte transport. J Clin Invest. 1976;58:83-90.
39. Skott P, Hother-Nielsen O, Bruun NE, Giese J, Beck-Nielsen H, Parving HH. Effects of insulin on kidney function and sodium excretion in health subjects. Diabetologia. 1989;32:694-669.
40. Doria A, Fioretto P, Avogaro A, et al. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol. 1991; 261:E684-E691.
41. Townsend RR, Zhao H. Plasma renin activity and insulin sensitivity in normoensive subjects. Am J Hypertens. 1994;7:894-898.
42. Egan BM, Stpniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994;7:886-893.
43. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM. Serum insulin and incident of coronary heart disease in middle-aged British men. Am J Epidemiol. 996;144:224-234.